Big Pharma
-
News
The excellence of the Italian pharmaceutical sector in the Nomisma Observatory dedicated to "Fab13"
The excellence of the Italian pharmaceutical sector in the Nomisma Observatory dedicated to "Fab13" Nomisma – 26 April 2023 The 13 champion companies of…
Leggi » -
News
ALFASIGMA: a difficult comparison
We report in full the unitary union statement drawn up after the last meeting between the workers' representatives and the ALFASIGMA company assisted by…
Leggi » -
First floor
Janssen Italy. To intercept opportunities, informers are cut.
The unions take to the streets and call a strike against the layoffs at Janssen of Cologno Monzese, a pharmaceutical company in…
Leggi » -
News
The EU Commission's legislative proposals seriously damage the competitiveness of the European pharmaceutical industry
The EU's long-term competitiveness strategy must be applied to EU pharmaceutical legislation EFPIA – 21.03.2023 EFPIA invites…
Leggi » -
News
Novartis will proceed with the repurchase of treasury shares (buyback)
A maxi-share buyback program starts for Novartis Share buybacks continue at Novartis: starting tomorrow a…
Leggi » -
News
The importance of pharmaceutical company reputation in prescribing
Pharma: reputation translates into prescription Daily Health Industry – March 1, 2023 Healthcare professionals consider reputation…
Leggi » -
News
Soon antibiotics won't work anymore and then it will be much worse than a pandemic
Sigfrido Ranucci's team, thanks to the investigative work of journalists Ciccolella and Valesini, uncovers a gigantic topic that risks…
Leggi » -
News
R&D spending doesn't justify high drug prices. An analysis on the BMJ
The "British medical journal" published an interesting analysis entitled "High drug prices are not ...
Leggi » -
News
Deloitte reports. In 2022, the rate of return on investment has decreased. The top 20 companies spent 139 billion on R&D
"Measuring the return from pharmaceutical innovation 2022", the thirteenth annual report of the Deloitte Center for Health, has been published. The…
Leggi » -
News
The EU wants to shorten the term of patents on medicines by two years
The EU clashes with Big Pharma over the price of drugs Corriere PL – 5 February 2023 – By Diletta Fileni The reforms…
Leggi »